218 related articles for article (PubMed ID: 32425503)
21. [The Boston keratoprosthesis].
Wang L; Huang Y; James C; Dohlman CH
Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):307-12. PubMed ID: 24931158
[TBL] [Abstract][Full Text] [Related]
22. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
23. [Boston keratoprosthesis: 73 eyes from Germany : An overview of experiences from two centers].
Schaub F; Neuhann I; Enders P; Bachmann BO; Koller B; Neuhann T; Cursiefen C
Ophthalmologe; 2018 Sep; 115(9):744-753. PubMed ID: 29043440
[TBL] [Abstract][Full Text] [Related]
24. Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review.
Al Arfaj K
Saudi J Ophthalmol; 2015; 29(3):212-21. PubMed ID: 26155082
[TBL] [Abstract][Full Text] [Related]
25. International results with the Boston type I keratoprosthesis.
Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of Boston keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft.
Hou JH; de la Cruz J; Djalilian AR
Cornea; 2012 Dec; 31(12):1432-5. PubMed ID: 22236785
[TBL] [Abstract][Full Text] [Related]
27. Experience with Boston keratoprosthesis type 1 in the developing world.
de Oliveira LA; Pedreira Magalhães F; Hirai FE; de Sousa LB
Can J Ophthalmol; 2014 Aug; 49(4):351-7. PubMed ID: 25103652
[TBL] [Abstract][Full Text] [Related]
28. The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure.
Chan CC; Biber JM; Holland EJ
Cornea; 2012 Nov; 31(11):1264-72. PubMed ID: 22406944
[TBL] [Abstract][Full Text] [Related]
29. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
Verdejo-Gómez L; Peláez N; Gris O; Güell JL
Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
[TBL] [Abstract][Full Text] [Related]
30. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
31. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
[TBL] [Abstract][Full Text] [Related]
32. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
33. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.
Cade F; Grosskreutz CL; Tauber A; Dohlman CH
Cornea; 2011 Dec; 30(12):1322-7. PubMed ID: 22001817
[TBL] [Abstract][Full Text] [Related]
34. The cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure.
Biber JM; Skeens HM; Neff KD; Holland EJ
Cornea; 2011 Jul; 30(7):765-71. PubMed ID: 21325942
[TBL] [Abstract][Full Text] [Related]
35. Titanium Boston keratoprosthesis with corneal cell adhesive and bactericidal dual coating.
Gómez SG; Guillem-Marti J; Martín-Gómez H; Mas-Moruno C; Ginebra MP; Gil FJ; Barraquer RI; Manero JM
Biomater Adv; 2023 Nov; 154():213654. PubMed ID: 37837906
[TBL] [Abstract][Full Text] [Related]
36. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
Driver TH; Aravena C; Duong HNV; Christenbury JG; Yu F; Basak SK; Aldave AJ
Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
[TBL] [Abstract][Full Text] [Related]
38. Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.
Iyer G; Srinivasan B; Agarwal S; Ravindran R; Rishi E; Rishi P; Krishnamoorthy S
Ocul Surf; 2019 Jan; 17(1):50-54. PubMed ID: 30157458
[TBL] [Abstract][Full Text] [Related]
39. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
